283 related articles for article (PubMed ID: 15964132)
1. Do prostatic infarction, prostatic inflammation and prostate morphology play a role in acute urinary retention?
Tuncel A; Uzun B; Eruyar T; Karabulut E; Seckin S; Atan A
Eur Urol; 2005 Aug; 48(2):277-83; discussion 283-4. PubMed ID: 15964132
[TBL] [Abstract][Full Text] [Related]
2. Relation between acute urinary retention, chronic prostatic inflammation and accompanying elevated prostate-specific antigen.
Kefi A; Koseoglu H; Celebi I; Yorukoglu K; Esen A
Scand J Urol Nephrol; 2006; 40(2):155-60. PubMed ID: 16608815
[TBL] [Abstract][Full Text] [Related]
3. Holmium laser prostatic resection for patients presenting with acute urinary retention.
Anderson CB; Helfand BT; McVary KT
BJU Int; 2008 Dec; 102(11):1623-8. PubMed ID: 18710443
[TBL] [Abstract][Full Text] [Related]
4. [Histological changes of the prostate and acute urinary retention in patients with benign prostatic hyperplasia].
Bao QB; He GH; Liu GY; Zhang CG; Yang C
Zhonghua Nan Ke Xue; 2013 Sep; 19(9):811-4. PubMed ID: 24386860
[TBL] [Abstract][Full Text] [Related]
5. Prostate size influences the outcome after presenting with acute urinary retention.
McNeill AS; Rizvi S; Byrne DJ
BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
[TBL] [Abstract][Full Text] [Related]
6. [Serum PSA and transition zone index as predictors of acute urinary retention in benign prostate hyperplasia].
Zhu S; Chen S; Li Q; Lin Z; Zheng S; Weng M
Zhonghua Nan Ke Xue; 2004 Jan; 10(1):24-5. PubMed ID: 14979202
[TBL] [Abstract][Full Text] [Related]
7. Definition of at-risk patients: dynamic variables.
Emberton M
BJU Int; 2006 Apr; 97 Suppl 2():12-5; discussion 21-2. PubMed ID: 16507047
[TBL] [Abstract][Full Text] [Related]
8. Definition of at-risk patients: baseline variables.
Roehrborn CG
BJU Int; 2006 Apr; 97 Suppl 2():7-11; discussion 21-2. PubMed ID: 16507046
[TBL] [Abstract][Full Text] [Related]
9. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
[TBL] [Abstract][Full Text] [Related]
10. Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily.
Emberton M; Elhilali M; Matzkin H; Harving N; van Moorselaar J; Hartung R; Alcaraz A; Vallancien G;
Urology; 2005 Aug; 66(2):316-22. PubMed ID: 16098361
[TBL] [Abstract][Full Text] [Related]
11. Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.
Roehrborn CG
BJU Int; 2006 Apr; 97(4):734-41. PubMed ID: 16536764
[TBL] [Abstract][Full Text] [Related]
12. Peak flow rate is the best predictor of acute urinary retention following prostate brachytherapy: our experience and literature review.
Ikeda T; Shinohara K
Int J Urol; 2009 Jun; 16(6):558-60. PubMed ID: 19456987
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of PSA in the detection of carcinoma of the prostate in patients presenting with acute urinary retention.
McNeill SA; Hargreave TB
J R Coll Surg Edinb; 2000 Aug; 45(4):227-30. PubMed ID: 11130021
[TBL] [Abstract][Full Text] [Related]
14. A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride.
Issa MM; Runken MC; Grogg AL; Shah MB
Am J Manag Care; 2007 Feb; 13 Suppl 1():S10-6. PubMed ID: 17295600
[TBL] [Abstract][Full Text] [Related]
15. Does open radical retropubic prostatectomy decrease the risk of acute urinary retention?
Tareen B; Godoy G; Laze J; Lepor H
Urology; 2008 Oct; 72(4):821-4. PubMed ID: 18602148
[TBL] [Abstract][Full Text] [Related]
16. Open prostatectomy for benign prostate hyperplasia: short-term outcome in 3000 consecutive patients.
Zargooshi J
Prostate Cancer Prostatic Dis; 2007; 10(4):374-7. PubMed ID: 17549069
[TBL] [Abstract][Full Text] [Related]
17. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
Desgrandchamps F; De La Taille A; Doublet JD;
BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
[TBL] [Abstract][Full Text] [Related]
18. The natural history of benign prostatic hyperplasia.
Fitzpatrick JM
BJU Int; 2006 Apr; 97 Suppl 2():3-6; discussion 21-2. PubMed ID: 16507045
[TBL] [Abstract][Full Text] [Related]
19. [The effect of acute urinary retention on serum prostate specific antigen concentration].
Hua LX; Wu HF; Sui YG; Cheng SG; Xu ZQ
Zhonghua Nan Ke Xue; 2002; 8(2):134-5. PubMed ID: 12479031
[TBL] [Abstract][Full Text] [Related]
20. Management outcome of acute urinary retention: model of prediction.
Daly P; Connolly S; Rogers E; Sweeney P
Urol Int; 2009; 83(1):39-43. PubMed ID: 19641357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]